Search News

Corporate Industry Technology Medical Updates

high-end medical devices

Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Corporate
Dr. Po-Lin Hsu Named on List of Forbes China - 100 Outstanding Overseas Returnees 2022-12-14
Corporate
magAssist is on the list of Forbes Asia 100 to Watch 2022 2022-09-09
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24
Corporate
2021 BlackBOX Melbourne X magAssist: A Collision between Design and Innovation 2021-12-28
Corporate
magAssist was named a potential unicorn company in Jiangsu Province 2021-12-02
Technology
magAssist receives keen international attention at the 47th European Society for Artificial Organs Congress 2021-09-13
Medical Updates
Percutaneous Ventricular Assist Device jointly developed by Ge Junbo’s team of Zhongshan Hospital affiliated to Fudan university and magAssist has made ground-breaking achievements 2021-07-17
Technology
The Organ Care System jointly developed by Wuhan Union Hospital and magAssist has ushered in a breakthrough 2021-07-05
Medical Updates
Zhongshan Hospital and magAssist Percutaneous Ventricular Assist Device Cooperation Kick-off Meeting Successfully Held 2020-09-07

Tabs： percutaneous ventricular assist device, myocardial infarction, maglev artificial heart technology, end-stage respiratory failures, VA-ECMO, ESA, the application of MoyoAssist, portable ECMO, severe shortage of heart donors, Potential Unicorn,